Session » Pediatric Rheumatology - Clinical and Therapeutic Aspects: Pediatric Lupus, Scleroderma and Myositis (ACR)
-
Abstract Number: 1294
Gender Differences in the Lupus Nephritis Biomarkers in Children
-
Abstract Number: 1295
Childhood-Onset Systemic Lupus Erythematosus: Short-Term Treatment Response Rates in Proliferative Lupus Nephritis
-
Abstract Number: 1296
Pulse- Pediatric Update on Lupus in South Africa: Epidemiology and Management
-
Abstract Number: 1297
Safety and Efficacy of Rituximab in Pediatric Lupus and Other Rheumatic Diseases
-
Abstract Number: 1298
Macrophage Activation Macrophage Activation Syndrome: A Severe and Frequent Manifestation of Acute Pancreatitis in Childhood-Onset Compared to Adult Systemic Lupus Erythematosus Patients
-
Abstract Number: 1299
A Cross-Sectional Study of Mental Health Symptoms and Mental Health Care in Pediatric SLE/MCTD Patients and Their Peers
-
Abstract Number: 1300
Subclinical Right Ventricle Systolic Dysfunction By Two-Dimensional Speckle-Tracking Echocardiography in Childhood-Onset Systemic Lupus Erythematosus Patients
-
Abstract Number: 1301
Trabecular Bone Impairment Assessed By HR-pQCT in Juvenile-Onset Systemic Lupus Erythematous with Vertebral Fractures
-
Abstract Number: 1302
The Psychological Impact on Health-Related Quality of Life in Childhood-Onset Lupus
-
Abstract Number: 1303
Accuracy of Laboratory Measures and Clinical Renal Activity Indices for Reflecting Biopsy-Proven Lupus Nephritis (LN) Activity
-
Abstract Number: 1304
Development of an Index to Non-Invasively Quantify Lupus Nephritis Chronicity in Children
-
Abstract Number: 1305
Adiposity and Adipokines Are Associated with Insulin Resistance in Pediatric Systemic Lupus Erythematosus
-
Abstract Number: 1306
Outcome of Lupus Nephritis in Children Less Than 12 Years Old from North-India
-
Abstract Number: 1307
Monitoring of Mid-Interval Plasma Levels of Mycophenolic Acid in Pediatric Lupus Nephritis Patients
-
Abstract Number: 1308
Antinucleosome Antibodies As Potential Diagnostic and Prognostic Biomarkers in Childhood Onset Systemic Lupus Erythematosus
-
Abstract Number: 1309
Does Anti-C1q Antibody Have Diagnostic and Prognostic Roles in Childhood – Onset Systemic Lupus Erythematosus?
-
Abstract Number: 1310
Predicting Macrophage Activation Syndrome in Pediatric Systemic Lupus Erythematosus Patients at Diagnosis
-
Abstract Number: 1311
Lupus Nephritis in Mexican Children
-
Abstract Number: 1312
Features, Treatment and Outcome of Macrophage Activation Syndrome in Pediatric Systemic Lupus Erythematosus
-
Abstract Number: 1313
Comorbidity Patterns in Children with Juvenile Idiopathic Arthritis and Systemic Lupus Erythematosus: The Childhood Arthritis and Rheumatology Research Alliance Registry
-
Abstract Number: 1314
Comparison of the Utility and Validity of Three Scoring Tools to Detect Skin Disease in Patients with Juvenile Dermatomyositis
-
Abstract Number: 1315
Cross-Sectional Evaluation of Hydroxychloroquine (HCQ) Therapy in Children with Juvenile Dermatomyositis (JDM) Enrolled in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry
-
Abstract Number: 1316
A Hybrid Conjoint Analysis Model Is Proposed As the Definition of Minimal, Moderate and Major Clinical Improvement in Juvenile Dermatomyositis Clinical Trials
-
Abstract Number: 1317
Anti-p155/140 Autoantibodies and Selected Features at Illness Onset Are Associated with a Chronic Course of Illness in the Juvenile Idiopathic Inflammatory Myopathies
-
Abstract Number: 1318
Illness Onset Features and Misdiagnosis in Juvenile Idiopathic Inflammatory Myopathies (JIIM) Differ Among Clinical and Autoantibody (Ab) Subgroups
-
Abstract Number: 1319
Safety of Rituximab in Treating Pediatric Rheumatologic Disease
-
Abstract Number: 1320
Analysis of Risk Factors for Thrombosis in Pediatric Patients with Systemic Lupus Erythematosus
-
Abstract Number: 1321
A Pilot Study to Evaluate the Feasibility of Conducting Juvenile Localized Scleroderma Comparative Effectiveness Treatment Studies
-
Abstract Number: 1322
Cardiopulmonary Involvement in Juvenile Systemic Sclerosis: Development of Recommendations for Screening and Investigation
-
Abstract Number: 1323
Gastrointestinal Involvement in Juvenile Systemic Sclerosis: Development of Recommendations for Screening and Investigation
-
Abstract Number: 1324
Predictors of Disease Relapse in Juvenile Localized Scleroderma
-
Abstract Number: 1325
Single Hub and Access Point for Pediatric Rheumatology in Europe (SHARE): Evidence Based Recommendations for Diagnosis and Treatment of Juvenile Localized Scleroderma and Juvenile Systemic Sclerosis
-
Abstract Number: 1326
Transition of Care and Long-Term Outcomes of Juvenile Systemic Sclerosis during Adulthood: Results from a French Single-Center Case-Control Study
-
Abstract Number: 1327
Decreased CD3-CD16CD56+ Natural Killer Cell Counts Are Associated with Disease Activity in Children with Orbital Myositis